The pharmaceutical industry has been lagging behind other industries when it comes to digitization, but incumbents are now signaling their interest in digital health—and one of the most disruptive technology incumbents are tapping is AI to slash the time and resources needed to bring a drug to market.
WHAT’S IN THIS REPORT? In this report, Insider Intelligence outlines the various stages within the drug discovery and development process—noting where AI can be leveraged in to reduce costs and shrink time frames. We provide examples of startups working to employ AI at various stages, and explain how tech giants are making use of their AI brawn to forge alliances with pharma companies. Finally, we highlight the barriers that remain hindering AI's use in drug discovery and development.
Exportable files for easy reading, analysis and sharing.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844